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In vitro and in vivo anti-diabetic and anti-oxidant activities 
of methanolic leaf extracts of Ocimum canum 
 
Abstract 
Background: Diabetes is a metabolic disorder with a highly complex, multifaceted and 
intricate etiologies and thus may require management options that proffers multimodal 
mechanism of action. This present study evaluated the antidiabetic and antioxidant 
potential of the methanolic extract/fractions of leaves of Ocimum canum. 
Methods: The antidiabetic potential was evaluated and using STZ-induced diabetic Wistar 
rat model (in vivo) and inhibition of α-amylase and α-glucosidase activity (in vitro).  
Antioxidant activity was assessed in vitro by free radical scavenging and reducing power 
assays and in vivo via monitoring SOD and CAT activities; GSH and MDA levels. 
Results: The total phenolic content (221.0±3.0 mg catechol/g of sample) and tannins 
(146.0±4.0 mg tannic acid/g of sample) of the crude extract; and flavonoid of the aqueous-
methanol fraction (216.0.0±1.0 mg of rutin/g of sample) were found to be significantly 
higher relative to others. The crude extract and the aqueous-methanol fraction exhibited a 
significantly (p<0.05) higher percentage reduction in fasting blood glucose and a 
concomitant increase in serum insulin level relative to the diabetic control group. The 
highest radical scavenging activity and reducing power were observed in the aqueous-
methanol fraction. The aqueous-methanol solvent fraction also significantly reversed the 
alterations in oxidative stress markers occasioned by the diabetic condition. 
Conclusion: In conclusion, the result of the present study has demonstrated evidently that 
extracts of Ocimum canum leaves ameliorates hyperglycemia and the associated oxidative 
stress in STZ-induced rats.  
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Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia, 
hypertriglyceridemia and hypercholesterolemia, which results from defects in insulin 
secretion, its actions or both (1). The disorder is associated with an imbalance of the 
glycemic index and glucose intolerance, which increases the risk of individuals 
progressing to type 2 diabetes mellitus. Complications from diabetes, such as coronary 
artery and peripheral vascular diseases, stroke, diabetic neuropathy, risk of ulcers and 
amputations, renal failure, sexual dysfunction, and blindness accounts for the increasing 
disability, reduced life expectancy, and enormous health costs associated with this 
condition for virtually every society (2). The disease has attained great significance in the 
sub-Saharan region, with Nigeria being the most affected. Put in numbers, there are about 
387 million people with diabetes globally, of which 22 million reside in sub-Saharan 
Africa (3). It is becoming the third killer of mankind after cancer and cardiovascular 
disease due to its high prevalence, morbidity and mortality (4).  
 Caspian J Intern Med 2019; 10(2):162-175  
Ocimum canum extract ameliorates hyperglycemia and oxidative stress in diabetic wistar rats                               163 
The disease is a disorder with a complex and 
multifaceted etiology. The oxidative stress of hyperglycemia 
has extensively been implicated to be a central mechanism. 
For development, progression and complications of the 
condition, thus this necessitates the development of 
antidiabetic drugs with multimodal mechanism of action. 
Most of the antidiabetic drugs currently available act via one 
known mechanism and may also present with some 
undesirable effect when used. As alternatives, herbal remedy 
may provide a comparative advantage by reason of the 
presence or possession of diverse bioactive secondary 
metabolites which could exert their effect via different 
mechanisms (2, 4).  
Plants have been the basis of traditional medicine 
systems around the world for thousands of years. Even in 
modern-medicine systems, ethnobotanical treatments 
continue to play an important role in healthcare. About 80% 
of the populations in developing countries rely on traditional 
medicine for their healthcare (2). In Nigeria, Ocimum genus 
species form a significant part of the folk medicine system 
for the management of diabetes mellitus. However, this 
practice still suffers from lack of scientific validation of their 
efficacy, dosage, safety, and mechanisms of action. 
Furthermore, they represent a potential major source of lead 
compounds for treatment of diabetes mellitus. 
Ocimum canum is common specie in the genus of 
Ocimum. It is a natural growing herb, but is cultivated in 
some climes. It is characterized by a pungent aromatic flavor 
and commonly cultivated for culinary and medicinal 
purposes. It is used in preparing different local dishes as a 
spice as well as vegetable. It is a source of fragrance and 
aroma compounds (5, 6). 
The plant is used in traditional medicines to treat 
conjunctivitis, malaria and headache, high blood sugar and 
other ailments (7, 8). 
 Despite the use in management of metabolic conditions 
such as diabetes, there is still dearth of extensive scientific 
report on the antioxidant and antidiabetic activity of the 
leaves of this plant.  
Previously, Nyarko et al., and Dash et al. reported the 
hypoglycemic potentials of this plant, however, despite these 
studies, there are still some knowledge gaps that requires 
further work (9-11). This present study intends to screen the 
methanolic extract of the leaves of Ocimum canum for 
antioxidant and hypoglycemic activity as a first phase of 
characterization of this plant. 
Methods 
Experimental Animals: This research was carried out using 
fifty seven (57) Wistar rats of 150-180g weight range. The 
animals were obtained from the Department of Biological 
Sciences, Bayero University Kano State, housed and 
maintained at normal room temperature. They were placed 
on standard commercial feeds and clean water ad libitum and 
allowed to acclimatize for 2 weeks before the work proceeded. 
Plant materials: Ocimum canum leaves were obtained from 
Yankura Market in Sabon gari, Kano, and was identified and 
authenticated (voucher No: BUKHAN0306) by a taxonomist 
in the Department of Biological Science, Bayero University 
Kano State.  
Chemicals: All chemicals and kits used were of analytical 
grade 
Preparation of plant extracts: The extract and solvent 
fractions were prepared as described by Teke et al. with little 
modifications (12). The plant leaves were shade dried and 
coarsely powdered. A mass of 500 g of the ground leaves 
was macerated in 2.5L of methanol for 72 hours. It was then 
filtered and the solvent was evaporated under reduced 
pressure in a rotary evaporator at 50°C to afford 32g of 
methanol extract of Ocimum canum. The extract was labeled 
and preserved for further use. A mass of 20.14 g of this 
extract was pre-dissolved in 100 cm
3
 of methanol and then 
partitioned into n-hexane (350 cm
3 
x3) and the upper (n-
hexane) phase was collected and concentrated as n-hexane 
solvent fraction. The residual methanol phase was collected, 
concentrated and then re-dissolved in 100cm
3
 of aqueous-
methanol (55:45 v/v) and portioned into ethyl acetate (350 
ml x3). The resulting upper (ethyl acetate) phase was collected 
and concentrated as the ethyl acetate solvent fraction while 
the lower (aqueous-methanol) phase was collected and 
concentrated as the aqueous-methanol solvent fraction. All 
extract and fractions were labeled and preserved for further 
use. 
Phytochemical analysis: The phytochemical analysis of the 
extracts and fractions was carried out using the methods 
described by Sofowora (13), Harbourne (14) and Saeed et al. (15). 
Alkaloids:  A volume of 1cmᶟ of 1% HCl was added to 3 
cmᶟ of the extracts in a test tube. The mixture was heated for 
20 minutes, cooled and then filtered. The filtrate was used as 
follows. 
A. Two drops of Mayers reagent were added to 1cmᶟ of 
the extracts. A creamy precipitate indicated the presence of 
alkaloids in the extracts. 
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B. Two drops of Wagner’s reagent were added to 1cmᶟ 
of the extracts. A reddish brown precipitate indicated the 
presence of alkaloids 
Tannins:  A volume of 1cmᶟ of freshly prepared 10%w/v 
KOH was added to 1cmᶟ of the extracts. A dirty white 
precipitate indicated the presence of tannins.  
Phenolics: Two drops of 5% FeCl₃ were added to 1cmᶟ of 
the extracts in a test tube. A greenish precipitate indicated 
the presence of phenolics.  
Glycosides: A aliquot of 10 cmᶟ of 50% H₂SO₄ was added 
to 1cmᶟ of the extracts, the mixture was heated in boiling 
water for 15 minutes. Then, 10 cmᶟ of Fehling’s solution was 
added and the mixture boiled. A brick red precipitate 
indicated the presence of glycosides. 
Saponins: Frothing test: A volume of 2 cmᶟ of the extract in 
a test tube was vigorously shaken for 2 minutes. Frothing 
indicated the presence of saponins. 
A. Emulsion test: Five drops of olive oil were added to 3 
cmᶟ of the extract in a test tube and vigorously shaken. A 
stable emulsion formed indicated the presence of saponins. 
Flavonoids: An aliquot of 1cmᶟ of 10% NaOH was added to 
3cmᶟ of the extracts. A yellow colouration indicated the 
presence of flavonoids. 
Steroids: Salkowsti test: Five drops of concentrated H₂SO₄ 
were added to 1cmᶟ of the extracts. A red colouration 
indicated the presence of steroids 
Phlobatannins: An aliquot of 1cmᶟ of the extracts was 
added to 1%v/v HCl. A red precipitate indicated the presence 
of phlobatannins. 
Triterpenes: Five drops of acetic anhydride were added to 
1cmᶟ of the extracts. A drop of concentrated H₂SO₄ was then 
added and the mixture was steamed for 1 hour and 
neutralized with NaOH followed by the addition of 
chloroform. A blue green color indicated the presence of 
triterpenes. 
Carotenoids: A gram of each sample was extracted with 10 
ml of chloroform in a test tube with vigorous shaking. The 
resulting mixture was filtered and 85% sulphuric acid was 
added. A blue color at the interface showed the presence of 
carotenoids. 
Estimation of total phenolic content: The total phenolic 
content was determined spectrophotometrically according to 
the method described by Saeed et al. (15) with slight 
modifications.  To a 10 cm
3
 test tube containing 0.1cm
3
 of 
extracts (in triplicates), 5.0 cm
3
 of distilled water and 0.5 cm
3
 
of (10% v/v) Folin-Ciocalteu’s phenol reagent prepared in 
water were added sequentially and shaken. After 5 minutes, 
0.5 cm
3
 of 2% Na2CO3 solution was added and mixed 
thoroughly. The mixture was kept in the dark for 30 min at 
room temperature, after which the absorbance was read 
against a blank (all reagents with methanol substituting the 
extract) at 765 nm. The standard curve for total phenolics 
was made using catechol standard solution (0 to 100 mg/l) 
following the same procedure as earlier described for the 
extracts. The total phenolics were determined from the 
standard curve and expressed as milligrams of catechol 
equivalent per g of dried extracts (crude extracts or fractions) 
Estimation of total flavonoid content: Total flavonoid 
content was determined following a method by Saeed et al. 
(12) with slight modifications. To a 10 cm
3
 test tube 
containing 0.3 cm
3
of extracts (in triplicates), 3.4 cm
3
 of 30% 
methanol, 0.15 cm
3
 of NaNO2 (0.5 M) and 0.15 cm
3
 of 
aluminium chloride (AlCl3.6H2O (0.3 M)) were added 
sequentially. After 5 min, 1 cm
3
 of NaOH (1 M) was added. 
The solution was shaken to mix well and the absorbance of 
the resulting solutions was measured against the reagent 
blank (all reagents with methanol substituting extract) at 506 
nm. The standard curve for total flavonoids was made using 
a standard solution of rutin (0 to 100 mg/l) following the 
same procedure as earlier described for the extracts. The 
total flavonoids were determined from the standard curve 
and expressed as milligrams of rutin equivalentper g of 
extracts (crude extracts or fractions). 
Determination of tannin content: The tannins were 
determined by the Folin - Ciocalteu method according to 
Saeed et al. (15) with slight modifications. To a 10 cm
3
 test 
tube containing 0.1 ml of the sample extract (in triplicates), 
7.5 cm
3
 of distilled water and 0.5 cm
3 
of Folin-Ciocalteu 
phenol reagent was added and shaken, after 5 mins, 1cm
3
 of 
2 % Na2CO3 solution was added and mixed thoroughly. The 
mixture was kept in the dark at room temperature for 30 
mins to develop color. The absorbance for the test and 
standard solutions was measured against a blank (all reagents 
with methanol substituting extract) at 725 nm. The standard 
curve for tannin was made using tannic acid standard 
solution (0 to 100 mg/l) following the same procedure as 
earlier described for the extracts.  The tannin content was 
expressed as milligrams of (tannic acid equivalence) TAE/g 
of dried crude extract or fractions.  
Determination of β-carotene and lycopene content: B-
carotene and lycopene were determined simultaneously 
according to the method of Nagata and Yamashita (16). A 
 Caspian J Intern Med 2019; 10(2):162-175  
Ocimum canum extract ameliorates hyperglycemia and oxidative stress in diabetic wistar rats                               165 
sample of extract weighing 0.1g was extracted with 4 cm
3
 of 
acetone-hexane (4:6 by volume) at 37
o
C for 10 min in 
triplicates.  
The resulting solutions were centrifuged and the 
absorbance of the supernatant taken at following 
wavelengths: 663 nm, 645 nm, 505 nm and 453 nm. The β-
carotene and lycopene content was determined per 100cm
3 
by the following equations and subsequently expressed per 
gram of sample: 
Lycopene (mg/100 cm
3
) = -0.0458A663 +0.204A645 
+0.372A505-0.0806A453 
B-carotene (mg/100 cm
3
) = 0.216A663 - 1.22A645 - 0.304A505-
0.452A453 
Where A663, A645, A505 and A453 are absorbance at 663, 645, 505, 
and 452 nm 
α-Amylase and α-glucosidase inhibition assay: The effect 
of the plant crude extract and solvent fractions on α-amylase 
and α-glucosidase activity was determined according to the 
method described by Kazeem et al. (17) with modifications.  
α-amylase: To 250ul of each extract concentration in a test 
tube (0-360 ug/ml), the following were added sequentially: 
buffered α-amylase (250µL, 0.05 mg/ml), starch (250µL, 
1%), the reaction mixture was incubated for 10 min at 25
o
C.  
DNSA (500µl) was added subsequently and then boiled for 5 
mins. It was then cooled and diluted with 5 ml of dH2O. The 
control was prepared in the same manner as the test samples 
with distilled water replacing the extract. The absorbance of 
each test tube content was taken at 540 nm and the 
percentage inhibition was calculated as follows; 
% Inhibition=       where Ac and At are the 
absorbance of the control and tests, respectively. 
The concentration of the extracts resulting in 50% 
inhibition of the enzyme activity (IC50) was determined 
graphically. 
α-glucosidase : To 50ul of each extract concentration in a 
test tube (0-40ug/ml) the following were added sequentially: 
buffered α-glucosidase (100µL, 1.0U/ ml) and incubated at 
37
o
C for 10minutes, then pNPG (50µl, 3.0 mM) and 
incubated at 37
o
C, for 20 min, then Na2CO3  (5%w/v), 
cooled to 25
o
C and lastly 5 ml H2O was added and vortexed. 
The absorbance of the yellow p-nitrophenol from the 
different test tubes will be taken at 405 nm and the 
percentage inhibition was calculated as follows; 
% Inhibition=       where Ac and At are the 
absorbance of control and tests respectively 
The concentration of the extracts resulting in 50% 
inhibition of the enzyme activity (IC50) will be determined 
graphically 
Acute toxicity (LD50) study: The acute toxicity (LD50) test 
of the methanol extract of leaves of Ocimum canum was 
determined using Lorke’s method (18). The crude methanol 
extracts were prepared in DMSO (10%v/v). The test was 
carried out in two phases. The first phase involved the use of 
nine (9). Wistar rats randomly distributed into three groups. 
The groups were administered 10, 100 and 1000 mg/kg body 
weight of the extract orally. The animals were monitored for 
24 hours for gross behavior and mortality. The second phase 
involved three (3). Wistar rats. Three different doses of 
1600, 2900 and 5000 mg/kg body weight of the extract were 
administered to each rat. The animals were monitored for 24 
hours for mortality. The LD50 was calculated as the 
geometric mean of the maximum dose that caused 0% death 
and the minimum dose that caused 100% death. 
Induction of Diabetes: Experimental diabetes was induced 
as described by Juarez-Rojop et al. (19) with modifications. 
Following overnight fasting, a single intraperitoneal 
injection of streptozotocin (60 mg/kgbw) dissolved in sterile 
water for injection was administered. This was followed by 
an oral administration of 5w/v% glucose solution two hours 
after induction. The control animals received the sterile 
water as placebo. The animals were checked for successful 
induction of diabetes after 48 hours. Animals with blood 
glucose above 300mg/dl were classified as diabetic.  
Experimental Design: The animals (45 in number) were 
weighed and randomly assigned to groups (n=5) of 
treatments as follows; 
Grp 1 (NDBC): Normal rats administered with DMSO+ food 
and water  
Grp 2 (DBC): Diabetes – induced rats administered 
DMSO+food and water  
Grp 3 (CROC1): Diabetes – induced rats administered with 
100 mg/kgbw of OC +food + H2O 
Grp 4 (CROC2): Diabetes – induced rats administered with 
200 mg/kgbw of OC +food + H2O       
Grp 5 (CROC3): Diabetes – induced rats administered with 
300 mg/kgbw of OC +food + H2O 
Grp 6 (HXOC): Diabetes – induced rats + hexane fraction of 
OC (100 mg/kgbw) +food + H2O 
Grp 7 (ETOC): Diabetes – induced rats + ethylacetate 
fraction of OC (100 mg/kgbw) +food + H2O 
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Grp 8 (HMOC): Diabetes – induced rats + aqueous-methanol 
fraction of OC (100 mg/kgbw) +food + H2O 
Grp 9 (GLMD): Diabetes –induced rats + 5 mg/kg bw of 
glibenclimide (standard drug) + food + H2O 
 OC= Ocimum canum, DMSO: Dimethylsulfoxide 
Determination of blood glucose and collection of blood 
and organ samples: The treatments were administered daily 
for 28 and 15 days with the crude extract and the solvent 
fractions respectively. Blood glucose was determined on a 
daily basis using accucheck glucometer, blood samples were 
collected via a slight incision on the lateral tail vein using a 
scalpel blade. The measurements were taken in duplicates to 
ensure consistency in the glucometer readings. After the last 
day of treatment, the rats were sacrificed under light 
anesthesia following a 12-hour fast (19), blood samples were 
collected, centrifuged and the serum stored for biochemical 
assays. The pancreas and liver were excised immediately, 
washed with chilled isotonic saline and stored in 10% formal 
saline and at -4
o
C in phosphate buffered saline (1.0X) 
respectively for further analysis. 
Determination of serum insulin: Serum insulin was 
determined using Accu Bind ELISA Microwell Insulin Test 
System (product code: 2425-300) according to the 
manufacturer’s manual. 
Histopathological assessment: Histopathological 
examinations were carried out on the pancreas of the rats. 
They were fixed in 10% formalin, dehydrated in graded 
ethanol concentrations (50-100%), cleared in toluene and 
embedded in paraffin. Sections (4-6 μM thick) were prepared 
and then stained with Hematoxylin and Eosin (H-E) dye for 
photomicroscopic observation under light microscope at high 
power magnifications (x 400 objectives). The stained section 
was observed with Leica DMTSO microscope and 
photographed with Leica ICC50 HD camera (20). 
Determination of in vitro antioxidant activity of the 
extract: The in vitro antioxidant activity of the methanol 
crude extract /solvent fractions of Ocimum canum were 
determined according to the methods described in Saeed et 
al. (15). 
DPPH assay (2, 2-diphenyl-1-picrylhydrazyl): The free 
radical scavenging activity of the extracts was determined in 
vitro by 2,2′-diphenyl-1-picrylhydrazyl (DPPH) method. 
Briefly, DPPH stock solution (0.1mM) was prepared by 
dissolving 4 mg of DPPH in 100 ml methanol and stored at 
20°C until required. The working solution was obtained by 
diluting the DPPH solution with methanol to attain an 
absorbance of about 1.2±0.09 at 517 nm using the 
spectrophotometer. A 3 cm
3
 aliquot of this solution was 
mixed with 100μl of the various concentrations (0-100 
μg/cm3). The reaction mixture was shaken well and 
incubated in the dark for 30 min at room temperature. The 
absorbance was taken at 517 nm. The control was prepared 
as described above with methanol substituted for the sample. 
The % scavenging activity was determined by the following 
equation: 
DPPH scavenging activity (%) = [(control 
absorbance−sample absorbance)/ (control absorbance)]×100 
Phosphomolybdate assay (total antioxidant capacity): 
The total antioxidant capacity was evaluated by the reduction 
of phosphomolybdate (VI) to phosphomolybdate (V) blue 
complex (15).  Briefly, an aliquot of 0.1cm
3
of sample 
solution was mixed with 1cm
3
of reagent solution (0.6M 
sulphuric acid, 28 mM sodium phosphate and 4 mM 
ammonium molybdate). The tubes were capped and 
incubated in a water bath at 95°C for 90 min. After the 
samples had cooled to room temperature, the absorbance of 
the mixture was measured at 765 nm against a blank. 
Ascorbic acid was used as standard. The antioxidant capacity 
was estimated using the following formula: 
Total antioxidant capacity (%) = [(control absorbance – 
sample absorbance)/(control absorbance)]×100   
Superoxide ion scavenging assay: The superoxide 
scavenging activity of the extract was determined according 
to the method described in Saeed et al.’s study (15). Briefly, 
a 1cm
3
aliquot of different concentrations (0-150μg/cm3) of 
the extract was mixed with 0.5 ml of phosphate buffer (50 
mM, pH 7.6), 0.3 cm
3 
riboflavin (50 mM), 0.25 ml PMS (20 
mM), and 0.1 ml NBT (0.5 mM) sequentially. The reaction 
was initiated by illuminating the reaction mixture using a 
fluorescent lamp. After 20 min of incubation, the absorbance 
was measured at 560 nm. Ascorbic acid was used as 
standard. The scavenging ability of the plant extract was 
determined by the following equation: 
       Scavenging activity (%)=(1−(absorbance of 
sample/absorbance of control)×100 
Hydroxyl radical scavenging assay: The superoxide 
scavenging activity of the extract was determined according 
to the method described in Saeed et al. study (15). Briefly, 
the reaction mixture contained; 500 μl of 2-deoxyribose (2.8 
mM) in phosphate buffer (50 mM, pH 7.4), 200 μl of 
premixed ferric chloride (100 mM) and EDTA (100 mM) 
solution (1:1; v/v), 100 μl of H2O2 (200 mM) with 100μl 
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graded concentrations (0-250μg/ml) of the extracts or 
without the extract for control. The reaction was triggered by 
adding 10μl of 300mM ascorbate and incubated for 1hour at 
37°C. A 0.5cm
3
 aliquot of the reaction mixture was taken 
and added to 1 cm
3 
of TCA (2.8% w/v aqueous solution), 
then 1cm
3
 of 1%w/v aqueous TBA was added to the reaction 
mixture. The mixture was heated for 15 min on a boiling 
water bath (100
o
C). The mixture was cooled and the 
absorbance at 532 nm was taken against a blank (the same 
solution but without the test solution). The hydroxyl 
scavenging activity of the extracts was calculated as follows: 
Scavenging activity (%) = (1−absorbance of 
sample/absorbance of control) ×100 
Reducing Power assay: The reducing power was based on 
Fe (III) to Fe (II) reductive transformation in the presence of 
the test samples that can be monitored by measuring the 
formation of Perl’s Prussian blue at 700 nm as described in 
(15). Briefly, various concentrations (0-200μg/ml) of the 
extract/fractions (2cm
3
) were mixed with 2cm
3
 of phosphate 
buffer (0.2 M, pH 6.6) and 2 cm
3
 of potassium ferricyanide 
(10 mg/cm
3
). The mixture was incubated at 50°C for 20 min 
followed by the addition of 2 cm
3
 of trichloroacetic acid (100 
mg/l). The mixture was centrifuged at 3000 rpm for 10 min 
to collect the supernatant of the solution. A volume of 2 cm
3
 
from each of the mixture earlier mentioned was mixed with 
2cm
3
of distilled water and 0.8 cm
3
 of 0.1% (w/v) fresh ferric 
chloride. After 10-min reaction, the absorbance was measured at 
700 nm. The higher absorbance of the reaction mixture 
indicates a higher reducing power. A standard curve of ferric 
sulphate was used to quantify the ferric reductive potential of 
the extract/fractions.  IC50 for reducing power assay was 
determined as the concentration of extract / solvent fraction 
that gave a reduction equivalence of 50mM Fe
2+
 
Determination of in vivo antioxidant activity:  
Tissue Preparation: Tissue homogenate (10%) was 
prepared by homogenizing 1g of frozen tissue in 10 ml of 
0.1M phosphate buffer at a pH of 7.4. The homogenate was 
centrifuged for 10 mins at 2500rpm/min. The supernatant 
was collected for the in vivo antioxidant assays. 
Reduced Glutathione and Glutathione Peroxidase (GSH-
PX): Reduced glutathione and glutathione peroxidase were 
determined according to the method described in the 
Elabscience GSH and GSH-Px assay kit (catalog No: 
BC0051) manufacturers manual. 
Superoxide Dismutase Activity (SOD): SOD was 
determined according to the method described by Gavali et 
al, (21) with slight modification. This method is based on the 
competitive inhibition of the autoxidation of pyrogallol 
under alkaline medium by SOD. The degree of inhibition is 
proportioned to the SOD activity. Briefly, to an aliquot of 
0.9 cm
3
 of phosphate buffered EDTA (1mM) solution, 0.05 
cm
3
 of the homogenate was added in a test tube, and shaken 
to mix. The reaction was started by adding 0.05cm
3
 of 
pyrogallol solution (20 mM). The absorbance was read at 
420mm exactly after 1 min and 30 secs. For the control, the 
procedure was repeated, but 0.1ml of buffer was added in 
place of the homogenate. The SOD activity was calculated as 
follows: 
Inhibition ratio=  Abs control - Abs sample x 100 
                                          Abs sample 
SOD activity (U/mg tissue/ml) = SOD inhibition ratio /50 
x Conc of sample (mg/ml) 
One unit of SOD is defined as the amount of the enzyme 
required to cause 50% inhibition of pyrogallol auto oxidation 
under the assay condition above 
Catalase Activity: Catalase activity was determined 
according to the method described by Prabhakar et al. (22). 
The method is based on the rate of decomposition of H2O2 
(hydrogen peroxide) by catalase which can be monitored at 
230-240 mm spectrophotometrically. Briefly, to 2.95 cm
3
 of 
H202 solution (0.1%v/v), 50µl of the homogenate was added. 
The decrease in absorbance was monitored at 230 nm for one 
minute. The catalase activity was calculated and expressed as 
mmol of H2O2 decomposed per minute per milligram of 
tissue as shown below: 
Catalase (U/ mg tissue/ml)  =  ΔAbs/ minute × 1000 
                                  43.6 × conc of tissue in sample 
Lipid Peroxidation: MDA was determined according to the 
method described by Prabhakar et al. (22) with slight 
modification. The method is based on MDA (the product of 
lipid Peroxidation) forming a complex that absorbs 
maximally at 532 nm with thiobatbituric acid (TBA). 
Briefly, an aliquot of 0.2 cm
3
 of the tissue homogenate was 
mixed with, 2 cm
3
 of thiobarbituric acid (TBA (0.375%)) -
trichloroacetic acid (TCA (15%)) reagent. The volume was 
made up to 3 cm
3
 with distilled water and then it was boiled 
in water bath at 95
o
C
 
for 20 mins. The solution was then 
cooled and the reaction product TBA – MDA complex was 
extracted by adding 3 cm
3
 of n-butanol to the resulting 
solution above. The absorbance of the pink coloured extract 
was measured at 532 nm using spectrophotometer. The 
amount of MDA was calculated using a molar extinction 
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coefficient of 1.56×10
5
M
-1
cm
-1
 and expressed as µmoles of 
MDA formed per gram of tissue as shown below. 
MDA (µmoles/g tissue/ml) = absorbance/1.56×10
5
 
*concentration of tissue in sample in (g/ml) 
 
Table 1: Qualitative phytochemical screening result of crude methanol extract and solvent fractions of Ocimum canum  
OC: Ocimum canum  CROC: Crude extract of OC,  HXOC: Hexane fraction of OC,  ETOC: ethylacetate fraction of OC, HMOC: aqueous-methanol fraction of OC 
 
Result 
 Acute toxicity: The LD50 of the crude extract was 
determined to be greater than 5000 mg/kgbw. This is 
considered non-toxic. 
Phytochemical analysis: The results of the qualitative and 
quantitative screening of the crude methanol extract and 
solvent fractions of Ocimum canum are presented in table 1 
and figure 1, respectively. Table 1 showed that saponin, 
phenolic, flavonoids, tannins, carotenoids, triterpenes and 
alkaloids were present in all the samples (crude and 
fractions). Figure 1 showed quantitatively the flavonoids, 
phenolic, tannins, lycopene and β-carotene content of all the 
samples.  A significantly (p<0.05) higher levels of 
flavonoids, phenolics and tannins were observed in the crude 
extract and the aqueous-methanol solvent fraction (HMOC). 
Conversely, the hexane and ethyl acetate solvent fractions  
revealed significantly (p<0.05) higher levels of carotenoids 
(lycopenes and β- carotenes). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Quantitative phytochemical contents of crude 
methanol extract and solvent fractions of leaves Ocimum canum  
OC: Ocimum canum, CROC: Crude extract of OC,   HXOC:Hexane fraction 
of OC,   ETOC: ethyl acetate fraction of OC,  HMOC: aqueous-methanol 
fraction of OC  
 
 
Values are mean ± SEM, n=3. Superscripts: Values 
(bars) bearing the same superscript are not statistically 
different (p>0.05). 
 In vitro antidiabetic activity: The result of the α-amylase 
and α-glucosidase inhibitory activity of the crude methanol 
extract of Ocimum canum and its solvent fractions is 
presented in table 2. The Ocimum canum leave 
extract/fractions showed a poor inhibition of α-amylase and 
α-glucosidase activities relative to the standard drug 
Acarbose with IC50s greater than 2500µg/ml. 
 
Table 2: Inhibitory effect (IC50) of crude methanol 
extract of Ocimum canum and its fractions on α-amylase 
and α-glucosidase activity in vitro 
Sample α-amylase IC50 
(µg/ml) 
α-glucosidase IC50 
(µg/ml) 
CROC 3135.5±60.0
c
 N.I 
HXOC 2802.0±58.0
b
 N.I 
ETOC 2945.8±137
b
 N.I 
HMOC 6803.6±786.0
b
 4239.8±337.0
b
 
ACAB 116.1±1.3
a
 482.05±7.4
a
 
OC: Ocimum canum CROC: Crude extract of OC, HXOC:Hexane fraction 
of OC, ETOC: ethylacetate fraction of OC, HMOC: aqueous-methanol 
fraction of OC, ACAB: Acarbose, NI: No significant inhibition. Values are 
mean ± SEM, n=3 Superscripts: Values bearing the same superscript along a 
column are not statistically different (p>0.05). 
 
In vivo antidiabetic activity: The result of the in vivo 
antidiabetic activity of the crude methanol extract and 
solvent fractions Ocimum canum leaves is presented in 
figure 2, figure 3 and table 3. The crude methanol extract 
(CROC) and the standard drug glibenclimide (GLMD) 
significantly (p<0.05) reduced the fasting blood glucose of 
the diabetic Wistar rats after 28 days in a dose-dependent 
Samples Saponins Phenolics Flavonoids Tannins Steroids Carotenoids Phlobtanins Alkaloids Triterpenes Glycosides Cardenolides 
CROC ++ ++ ++ + - ++ - + ++ + - 
HXOC + + + + - ++ - + ++ - - 
ETOC ++ + + + - + - + + + - 
HMOC + + + + - + - + + ++ - 
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manner compared to the untreated diabetic rat (figure 2),  
this was evident from the 8
th
 day of treatment. The effect of 
the crude extract / solvent fractions on serum insulin level 
and the change in fasting blood glucose (in percentage) are 
presented in table 3. The crude extract at a dose of 300 
mg/kgbw (CROC3) and the standard drug, glibenclamide at 
5 mg/kgbw significantly reduced the fasting blood glucose 
by 78.88% and 74.57% after 28 days respectively. They also 
caused a slight increase in insulin level relative to the 
diabetic control group. For the solvent fractions, the highest 
percentage reduction in fasting blood sugar relative to the 
diabetic control and the other solvent fractions was observed 
with the aqueous-methanol solvent fraction with a concomitant 
significant (p<0.05) increase in serum insulin in the treated 
groups. This was evident from the 4
th
 day of treatment. The 
histopathological sections of the pancreas of the diabetic 
Wistar rats with different treatments are presented in figure 
4. The result showed that the normal control showed 
unremarkable pancreas, revealing evenly and densely 
distributed beta-cells. Some few scattered islet cells were 
observed in the groups treated with the aqueous-methanol 
and the ethyl acetate solvent fractions. The group treated 
with hexane solvent fraction and the diabetic control showed 
a highly distorted islet and acinar cells in their pancreas. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Effect of crude methanol extract of Ocimum canum on fasting blood glucose of diabetic wistar rats  
OC:Ocimum canum, CROC1: administered with crude methanol extract of OC (100 mg/kgbw), CROC2: administered with crude methanol extract of OC (200 
mg/kgbw), CROC3: administered with crude methanol extract of OC (300 mg/kgbw), GLMD: administered  with glibenclamide  (5 mg/Kgbw), DBC: Diabetic 
control administered 10% DMSO, NDBC: Non-diabetic control administered 10% DMSO. Values are mean ± SEM, n=5.  a statistically different from  diabetic 
untreated control group (p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Effect of fractions of methanol extract of Ocimum canum on fasting blood glucose of diabetic Wistar rats 
OC: Ocimum canum, ETOC: administered with ethylacetate fraction of OC (100 mg/kgbw), HMOC: administered with aqueous-methanol fraction of OC (100 
mg/kgbw), HXOC: administered with hexan fraction of OC (100mg/kgbw), GLMD: administered with glibenclimide (5 mg/Kgbw), DBC: Diabetic control 
administered 10% DMSO, NDBC: Non-diabetic control administered 10% DMSO. Values are mean±SEM, n=5.  
 a  statistically different from  diabetic untreated control group (p<0.05).  
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Table 3: Effect of the crude methanol extract / solvent 
fractions of Ocimum canum on fasting blood glucose and 
serum insulin of diabetic wistar rats 
Gr
oups 
 
After 
induction 
After 
treatment 
Serum 
insulin 
(µIU/ml) 
Change 
in FBS 
(%) 
CROC1 370.4±28.9 157.0±7.5c 12.77±0.26d 57.60 
CROC2 366.4±7.2 114.5±8.1b 12.99±0.21d 68.75 
CROC3 437.2±28.7 127.07±10.7b 12.95±0.37d 69.81 
HMOC 419.0±69.6 200.5±12.9d 13.79±1.91bcd 52.60 
ETOC 378.0±56.3 263.5±14.5e 13.24±1.02bcd 24.40 
HXOC 387.0±34.7 308.0±20.1f 9.34±2.10a 20.41 
GLMB 472.0±39.1 124.3±37.6b 14.87±2.90b 73.60 
DBC 524.0±28.2 429.3±1.73h 9.20±0.24a 18.00 
NDBC 83.2±2.7 90.0±6.70a 15.6±0.56c ---- 
OC Ocimum canum, CROC1: administered with crude methanol extract of 
OC (100 mg/kgbw) ,  CROC2: administered with crude methanol extract of 
OC (200 mg/kgbw) ,  CROC3: administered with crude methanol extract of 
OC (300 mg/kgbw) ETOC: administered with ethylacetate fraction of OC 
(100 mg/kgbw), HMOC: administered with residual aqiueous-methanol 
fraction of OC (100 mg/kgbw), HXOC: administered with hexane fraction 
of OC (100 mg/kgbw), GLMB: administered with glibenclimide (5 
mg/Kgbw), DBC: Diabetic Control administered 10% DMSO, NDBC: Non-
diabetic control administered 10% DMSO. FBS: Fasting blood glucose. 
Values are mean ± SEM, n=5. Superscripts: Values bearing the same 
superscript along a column are not statistically different (p>0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Histological sections of pancreas of the treated 
diabetic Wistar rats (H&E, mag x 400). 
 OC: Ocimum canum, ETOC: administered with ethylacetate fraction of OC 
(100 mg/kgbw), HMOC: administered with aqueous-methanol fraction of 
OC (100 mg/kgbw), HXOC: administered with hexan fraction of OC (100 
mg/kgbw), GLMD: administered with glibenclimide (5 mg/Kgbw), DBC: 
Diabetic control administered 10% DMSO, NDBC: Non-diabetic control 
administered 10% DMSO  
In vitro antioxidant activity: The in vitro antioxidant 
activity of the crude extract and its solvent fractions are 
presented in figure 5. The methanol crude extract and the 
solvent fractions showed a dose-dependent antioxidant and 
radical scavenging activity. The activities observed were in 
the following orders: ASC>CROC>HMOC>ETOC>HXOC 
for Superoxide scavenging assay (SSA); 
ASC>HMOC>ETOC>CROC>HXOC, for hydroxyl 
scavenging assay (HSA); ASC>CROC>HMOC> 
ETOC>HXOC for DPPH scavenging assay (DSA); 
ASC>HMOC>CROC>ETOC>HXOC for ferric reducing 
power (FRAP); and ASC>CROC>ETOC>HMOC>HXOC 
for total antioxidant activity (TAC). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Antioxidant activity expressed in terms of IC50 
(µg/ml) of Ocimum canum leaf exracts/fractions 
OC: Ocimum canum, ETOC: ethylacetate fraction of OC, HMOC: aqiueous-
methanol fraction of OC, HXOC: hexane fraction of OC, ASC: Ascorbic 
acid. Values are mean ± SEM, n=3. Superscripts: Values bearing the same 
superscript along a column are not statistically different (p>0.05). 
 
In vivo antioxidant activity: The effect of the crude extract 
on oxidative stress markers is presented in figure 6 and table 
4. The result showed that the diabetic control had a 
significantly (p<0.05) lower GSH (reduced glutathione)  and 
higher MDA (malonaldehyde) level while the treated groups 
(CROC2, CROC3, GLMD) and normal control group 
(NDBC) had relatively higher GSH and lower MDA. Table 4 
presents the result of the effect of the solvent fractions of the 
methanol extract of Ocimum canum respectively on 
antioxidant status of diabetic wistar rats and non-diabetic 
wistar rats. The result showed that superoxide dismutase 
(SOD) and glutathione peroxidase (GSH-Px) increased in 
diabetic control group (DBC) relative to the normal control 
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(NDBC). The MDA level in DBC group was higher relative 
to other groups. The GSH level and catalase activity were 
significantly (p<0.05) lower in the diabetic control than in 
the normal control. The groups treated with the aqueous-
methanol solvent fraction had significantly lower SOD and 
GSH-Px when compared to the diabetic control group, but 
was lower than that observed in the normal control group. 
The GSH and catalase activity also showed similar trend - 
higher than what was observed in diabetic control but lower 
in the normal control. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Effect of crude methanol extract of Ocimum canum leaves on oxidative stress markers in diabetic Wistar rats. 
 OC: Ocimum canum, CROC2: administered with crude methanol extract of OC (200mg/kgbw), CROC3: administered with crude methanol extract of OC (300 
mg/kgbw), GLMD: administered with glibenclamide (5 mg/Kgbw), DBC: Diabetic control administered 10% DMSO, NDBC: Non-diabetic control administered 
10% DMSO. Values are mean±SEM, n=5. Superscripts: Values bearing the same superscript along a column are not statistically different (p>0.05). 
 
Table 4: Effect of fractions of methanol extract of Ocimum canum on oxidative stress markers in rats 
Groups GSH (mg/g of 
tissue) 
MDA(µmole/g of 
tissue) 
Catalase (U/g of 
tissue) 
SOD (U/mg of 
tissue) 
GSHPx(nmoleGSH/min/mg of 
tissue) 
HMOC 193.6±3.9
b
 76.22±4.98
a
 9.26±1.60
b
 0.142±0.02
c
 0.297±0.020
a
 
ETOC 184.6±10.6
a
 82.59±4.76
a
 9.68±1.40
b
 0.169±0.04
b
 0.313±0.020
b
 
HXOC 179.4±11.3
a
 88.40±7.3
a
 9.69±3.20
b
 0.181±0.06
b
 0.312±0.018
b
 
GLMD 186.8±6.9
a
 80.36±6.50
a
 9.23±0.63
b
 0.165±0.02
b
 0.308±0.005
b
 
DBC 171.2±6.8
a
 96.63±6.10
a
 7.5±1.90
a
 0.220±0.04
a
 0.329±0.005
b
 
NDBC 232.5±9.7
c
 57.72±1.39
b
 12.8±1.90
c
 0.120±0.01
c
 0.284±0.010
a
 
OC: Ocimum canum, ETOC: administered with ethylacetate fraction of OC (100 mg/kgbw), HMOC: administered with aqueous-methanol fraction of OC (100 
mg/kgbw), HXOC: administered with hexan fraction of OC (100 mg/kgbw), GLMD: administered with glibenclimide (5 mg/Kgbw), DBC: Diabetic Control 
administered 10% DMSO, NDBC: Non-Diabetic control administered 10% DMSO. Values are mean±SEM, n=5. Superscripts: Values bearing the same 
superscript along a column are not statistically different (p>0.05). 
 
Discussion 
The use of ethno botanicals has a long folkloric history 
for the treatment of diabetic conditions as well as oxidative 
stress-related conditions (1, 15); however, it still suffers from 
extensive scientific validation. Therefore, the search for 
more effective and safer antidiabetic/ hypoglycemic/ 
antioxidant agents remain an important area of research. In 
this present study, the leaves of Ocimum canum were  
evaluated for antidiabetic and antioxidant activity, owing to  
its use in ethnomedicine locally in southeastern part of 
Nigeria. The phytochemical analysis of crude extracts of 
Ocinum canum leaves revealed the presence of several 
phytochemicals: saponins, phenolics, flavonoids, tannins, 
carotenoids, alkaloids, triterpenes, and glycosides. The 
solvent fractions all had saponins, phenolics, flavonoids, 
tannins, carotenoids and alkaloids in common but in varying 
compositions. Steroids were found in the ethyl acetate 
fractions while lycopenes and β-carotenes were significantly 
higher in ethyl acetate and hexane fractions. This could be 
attributed to the solubility of these phytochemicals in 
solvents of different polarity. According to Martson and 
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Hostettman (23), polarity is an important factor that 
determines the solubility of compounds. Less polar 
flavonoids are more soluble in ethyl acetate, chloroform, 
diethyl ether while the more polar flavonoids are largely 
extracted with a mixture of water and alcohol. This explains 
the high flavonoid, tannin and phenolic contents in the 
aqueous-methanol fractions. Carotenoids are hydrophobic 
owing to their long hydrocarbon chains and as such are 
extractable by non-polar organic solvents (24).  
This finding is in line with the works of Iloki-Assanga et 
al. (25). Hexane fractions of Buceras L. and Phoradendron 
calofornicum revealed presence of carotenes, 
triterpenes/steroids, lactonic acid while the aqueous and 
ethanol fractions revealed the presence of diverse range of 
compounds including saponins, phenols, tannins, amines, 
amino acids and flavonoids/anthocyanins. α-amylase and α-
glucosidase are carbohydrate digesting enzymes. They are 
required to hydrolyze complex polysaccharides and 
disaccharides respectively to release glucose into the general 
circulation.  Inhibition of these enzymes has proven to be an 
efficient approach in controlling postprandial sugar (26). In 
this present study, The Ocimum canum crude extract and 
solvent fractions showed a poor inhibitory activity against 
the two enzymes relative to Acarbose, a standard drug that 
exerts its activity by inhibiting the aforementioned digestive 
enzymes. Ocimum genera have been reported widely to have 
antidiabetic potentials. Ocimum basilicum (27, 28), Ocimum 
tenuiflorum (29), Ocimum sanctum (28) have all been 
reported to exhibit strong inhibition against α-amylase and α-
glucosidase. However, this present study, Ocimum canum 
did not record any significant inhibitory activity against the 
two enzymes. This finding may be attributed to specie 
differences. Phytochemical composition is expected to vary 
to a degree between species within a genus (30). 
Streptozotocin has been shown to cause direct irreversible 
damage (necrosis) to β-cells of pancreatic islets of 
Langerhans, resulting in degranulation and consequent loss 
of insulin secretions. Clarification of the regenerating 
potential in experimentally-induced diabetic animal is of 
huge interest in finding alternative therapy for diabetes. Plant 
extracts with high polyphenolic contents have been reported 
to potentiate insulin secretion from residual and regenerated 
β-cells or its action of releasing bound insulin from β-cells, 
by inhibiting ATP sensitive K
+
 channels like Glibenclimide 
(31). In this present study, the crude extract and its aqueous-
methanol fraction significantly reduced the fasting blood 
sugar by 69.81% and 52.60%, respectively, and 
concomitantly increased the serum insulin levels in the 
treated diabetic Wistar rats. This activity may be linked to 
some class of compounds-phenolics, tannins and flavonoids- 
which were higher in the crude extract and aqueous-
methanol solvent fraction.  Histological sections of the 
pancreas showed that the normal control (NDBC) group and 
the group treated with standard drug, glibenclimide (GLMD) 
group revealed a large number of β-cells evenly distributed 
in the islets of Langerhans. In contrast, small-volumed and 
irregular shaped islets were observed in aqueous methanol 
(HMOC), and ethyl acetate fraction (ETOC) as against the 
diabetic control, DBC showed highly disordered islets and 
no visible β-cells. This observation suggests that this extract 
may contain compounds that protect the beta-cells from 
further oxidative damages, potentiate the secretion of insulin 
from the residual beta cells and consequently may activate 
the uptake of glucose by peripheral tissues such as muscle.  
Oxidative stress is a suggested mechanism for the 
induction and progression of diabetes and diabetic 
complications, which results from imbalance between 
prooxidants / radical generating and antioxidants/radical 
scavenging system (26). Hyperglycemia is strongly 
associated with increased superoxide generation via the 
mitochondrial system (32-34). Although it is a weak oxidant, 
it gives rise to the generation of powerful and dangerous 
hydroxyl radicals as well as singlet oxygen, both of which 
contribute to oxidative stress. The hydroxyl radical is 
regarded as a detrimental reactive oxygen species in 
pathophysiological processes and capable of damaging 
almost every biomolecule. It is also implicated in 
carcinogenesis, mutagenesis, cytotoxicity and pathogenesis 
of chronic disease (35).  The antioxidant activity of the 
extracts in vitro was evaluated by DPPH, O2
*
, HO
*
 
scavenging and reducing power assays. The result of this 
study revealed that the methanolic extract of Ocimum canum 
possesses phytochemicals with high capacity to scavenge 
free radicals and reduce highly damaging oxidative 
intermediates. These groups of phytochemicals may be 
largely more soluble in aqueous-methanol as shown by the 
quantitative phytochemical content and the median 
inhibitory concentrations (IC50s) for the different in vitro 
antioxidant assays of the aqueous methanol fraction of 
Ocimum canum relative to the other solvent fractions.  These 
components could be flavonoids and phenolics which have 
been shown to be highly antioxidative via their reducing 
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power or electron/hydrogen donating/transfer potentials (36).  
This finding is consistent with that reported by (37-39). 
Antioxidant enzymes as well as non-enzymatic antioxidants 
are the first line of defense against reactive oxygen species 
(ROS) induced oxidative damages in a living organism. 
Superoxide dismutase (SOD), glutathione peroxidase (GPx), 
and catalase (CAT) are the three major antioxidant enzymes 
that remove free radicals in vivo. SOD protects tissues 
against reactive oxygen species by dismutating superoxide 
into molecular oxygen and hydrogen peroxide which are also 
capable of damaging the cell membrane and other biological 
structures. CAT on the other hand is responsible for the 
detoxification of significant amounts of hydrogen peroxide 
(H2O2) (23). GPx plays a central role in the catabolism of 
H2O2 and detoxification of endogenous metabolic peroxides 
and hydroperoxides using reduced glutathione (GSH) (26). 
GSH functions as a free radical scavenger and is an essential 
co-substrate for GSH-Px (26). Lipid peroxidation is one of 
the characteristic features of chronic diabetes. The increased 
free radicals produced usually react with polyunsaturated 
fatty acids in cell membranes, leading to lipid peroxidation, 
which in turn results in elevated production of free radicals 
(26). In this present study, malonaldehyde, SOD and GSH-
Px activity increased significantly while GSH and CAT 
activity decreased in the diabetic control group compared to 
the normal control. Treatment with the crude methanol 
extract of Ocimum canum and its aqueous-methanol fraction 
significantly reversed these trends of antioxidant status in the 
diabetic rats to levels that compared with the normal control 
group. A significant difference was not observed between the 
glibenclimide treated and the diabetic control group. An 
indication that glibenclamide may not posse significant 
antioxidant activity. All the improved outcomes recorded 
with treatment of diabetes using glibenclimide might be 
attributable to its ability to ameliorate hyperglycemic 
condition which initiates and potentiates the oxidative stress 
in diabetic condition. The increased MDA and decreased 
level of GSH are indicative of oxidative stress in the 
untreated diabetic groups. The increased SOD and GSH-Px 
activity in the diabetic control group may be a compensatory 
mechanism to counter the high level oxidative stressors like 
superoxide, hydroxyl radicals and hydrogen peroxides which 
are common free radicals associated with hyperglycemic 
conditions. The extract/fraction which reversed this trend 
probably acted by assisting in mopping up some of the free 
radicals and reducing the strain on the antioxidant system. 
The decreased level of catalase in the untreated diabetic rats 
might be as a result of inhibition of the enzyme by high level 
of superoxide or glycation of the hemprotein as a result of 
hyperglycemia (40).  
Kono and Fridovich in 1982 demonstrated that 
superoxide specifically inhibits catalase activity using an 
enzymatic source of superoxide (41). This observation is the 
basis for the idea that SOD and catalase may be mutually 
protective set of enzymes. Hyperglycemia in diabetes leads 
to an overdrive of the electron transport chain in the 
mitochondria, which consequently results in the generation 
of excess superoxide radicals (40). The elevated blood 
glucose in the diabetic control rats could have enhanced 
superoxide radical generation which consequently inhibited 
the catalase activity. The high SOD and GSH-Px activity 
recorded in the diabetic untreated rats might be a 
consequence of increased superoxide and hydrogen peroxide 
generated by enhanced SOD as observed by Kharazi-Nejad 
et al. (42). There are conflicting results with regard to the 
GSH-Px CAT and SOD activity in diabetic condition in 
previous studies. Some studies reported reduced activities 
while some reported increased activity (26, 31, 40, 43). 
Kharazi-Nejad et al. (42) and Ramanathan et al. (44) 
reported increases in SOD and CAT following STZ-
induction of diabetes. Conversely, Anwar and Meki (42) 
reported a decline in the activity of these enzymes following 
a diabetic untreated condition. These differences in result 
may be accounted for by the following; degree of oxidative 
stress, nature of the stressors or inducing agents, mechanisms 
of oxidative assault and duration of assault condition or 
treatment. The inducing agents, inducing doses and 
treatment durations for some of the reported studies varied. 
In conclusion, the findings of this study show that the 
methanolic extract of Ocimum canum has high potential to 
ameliorate hyperglycemic condition as well as the associated 
oxidative stress. The aqueous-methanol solvent fraction 
exhibited the highest activity. This provides scientific 
evidence for the ethno medicinal use of this plant and a 
baseline data for further work to characterize the extract. 
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